Advertisement

CYP Polymorphism and Its Association with Tobacco Usage and Susceptibility to Head and Neck Cancer

  • A. Anuradha
  • V. Lakshmi Kalpana
  • Natukula Kirmani
  • Peela Jagannadha Rao
Chapter
Part of the SpringerBriefs in Applied Sciences and Technology book series (BRIEFSAPPLSCIENCES)

Abstract

Aim: To analyse the association between polymorphisms of CYP genes and the risk for head and neck cancer susceptibility. Materials and Methods: A case-control study using molecular epidemiological method was conducted. Various polymorphism of CYP1A1 gene from DNA samples of 105 cases and 110 controls were detected by PCR method. Results: All sites of CYP1A1 in HNC cases showed no significant results in relation to the three genotypes i.e., Ile/Ile, Ile/Val and Val/Val. Larynx is significant in relation to CYP2E1 I/I genotype whereas oral cavity and pharynx showed no significant results. In CYP1A1, except for Ile/Val, the other two Ile/Ile and Val/Val showed no significant results and in CYP2E1 all the genotypes i.e., I/I, I/I and i/I shows significant results. Together, all the three genotypes of CYP1A1(Ile/Ile, Ile/Val and Val/Val) were statistically significant whereas in CYP2E1 except I/I, the remaining two genotypes (I/I and i/i) were statistically significant. When combination of both the genes are considered, Ile/Val in CYP1A1 and I/i and i/I in CYP2E1 show high significance. Conclusion: CYP1A1 Ile/Val and CYP2E1 I/i and i/i genotypes showed genetic susceptibility biomarkers for head and neck cancers. Risk increases when the metabolic enzymes as products of these genes seem to interact with tobacco carcinogens, the mechanism of which is still not understood.

Keywords

Polymorphism Genotype Carcinogen 

References

  1. 1.
    Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127–135CrossRefGoogle Scholar
  2. 2.
    Ferlay J, Bray F, Pisani P, Parkin DM (2004) Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. IARC Press, Lyon, FranceGoogle Scholar
  3. 3.
    National Cancer Registry Programme (1992) Biennial report (1988–1989) of the national cancer registry programme. Indian Council of Medical Research, New DelhiGoogle Scholar
  4. 4.
    Parkin DM, Whelan SL, Ferlay J, Raymond LA, Woung J (1997) Cancer Incidence in five continents, vol VII, no 143. IARC Scientific Publications, LyonGoogle Scholar
  5. 5.
    Sanderson RJ, Ironside JA (2002) Squamous cell carcinomas of the head and neck. BMJ 325:822–827CrossRefGoogle Scholar
  6. 6.
    Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391–407CrossRefGoogle Scholar
  7. 7.
    Anttila S, Vainio H, Hietanen E, Camus AM, Malaveille C, Brun G (1992) Immunohistochemical detection of pulmonary cytochrome P-4501A and metabolic activities associated with P4501A1 and P4501A2 isozymes in lung cancer patients. Environ Health Perspect 98:179–182CrossRefGoogle Scholar
  8. 8.
    Hayes JD, Pulford DJ, Hayes JD, Pulford DJ (1995) The glutathione- S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445–600Google Scholar
  9. 9.
    Townsend DM, Tew KD (2003) Can cer drugs, genetic variation and the glutathione- S-transferase gene family. Am J Pharm Ecogenomics 3:157–172CrossRefGoogle Scholar
  10. 10.
    Park JY, Muscat JE, Ren Q et al (1997) CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomark Prev 6:791–797Google Scholar
  11. 11.
    Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-fl anking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem (Tokyo) 110:559–565Google Scholar
  12. 12.
    Miller SA1, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215Google Scholar
  13. 13.
    Murata M, Watanabe M, Yamanaka M et al (2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST)M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165:171–177CrossRefGoogle Scholar
  14. 14.
    Le Marchand L, Donlon T, Seifried A, Wilkens LR (2002) Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomark Prev 11:1019–1024Google Scholar
  15. 15.
    Wu X, Zhao H, Suk R, Christiani DC (2004) Genetic susceptibility to tobacco-related cancer. Oncogene 23:6500–6523CrossRefGoogle Scholar
  16. 16.
    McWilliams JE (2000) Genetic polymorphisms in head and neck cancer risk. Head Neck 22(6):609–617CrossRefGoogle Scholar
  17. 17.
    Masood N, Malik FA, Jabeen IM, Baig RM, Kayani MA (2011) A novel CYP1A1 gene polymorphism and the risk of head and neck cancer in Pakistani population. Afr J Biotechnol 10(27):5273–5280Google Scholar
  18. 18.
    Shanmugaratnam K (1982) Nasopharynx. In: Schottenfeld D, Fraumeni Jr. JF (eds) Cancer epidemiology and prevention. Saunders Company, Philadelphia, WB, pp 536–553Google Scholar
  19. 19.
    Llewellyn CD, Johnson NW, Warnakulasuriya KA (2004) Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 33:525–532CrossRefGoogle Scholar
  20. 20.
    Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H (1998) Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 20(3):216–223CrossRefGoogle Scholar
  21. 21.
    Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Sem Cancer Biol 12:421–429MATHCrossRefGoogle Scholar
  22. 22.
    Toefil L, Oana CT, Horea AA, Ovidiu M (2007) Head and neck cancer, epidemiology and histological aspects-Part 1: a decade’s results 1993–2002. J Cranio Maxill Surg 35(2):120–125CrossRefGoogle Scholar
  23. 23.
    Olshan AF, Weissler MC, Watson MA, Bell DA (2000) GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomark Prev 9:185–191Google Scholar
  24. 24.
    Pöschl G, Seitz HK (2004) Alcohol and cancer. Alcohol Alcohol 39:155–165CrossRefGoogle Scholar
  25. 25.
    Caro AA, Cederbaum AI (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27–42CrossRefGoogle Scholar
  26. 26.
    Li Z, Tan W, Shao K (2000) Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1. Chin J Oncol 22:5–7Google Scholar
  27. 27.
    Cheng YJ et al (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 89:1207–1212Google Scholar
  28. 28.
    Mittal RD, Srivastava DS (2005) A M, B M: Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in north India. Asian Pac J Cancer Prev 6:6–9Google Scholar
  29. 29.
    Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266:1–9CrossRefGoogle Scholar
  30. 30.
    Kim JW, Lee CG, Park YG et al (2000) Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88:2082–2091CrossRefGoogle Scholar
  31. 31.
    Sikdar N, Mahmud SA, Paul RR, Roy B (2003) Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 195:33–42CrossRefGoogle Scholar
  32. 32.
    Soya SS, Vinod T, Reddy KS, Gopalakrishnan S, Adithan C (2008) CYP2E1 polymorphisms and gene–environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics 9(5):551–560Google Scholar

Copyright information

© The Author(s) 2016

Authors and Affiliations

  • A. Anuradha
    • 1
  • V. Lakshmi Kalpana
    • 1
  • Natukula Kirmani
    • 2
  • Peela Jagannadha Rao
    • 3
  1. 1.Department of Human-GeneticsAndhra UniversityVisakhapatnam-26India
  2. 2.Department of GeneticsBhagavan Mahaveer Medical Research CenterHyderabadIndia
  3. 3.Faculty of MedicineQuest International University PerakIpohMalaysia

Personalised recommendations